...
首页> 外文期刊>Journal of Lipid Research >Shared reference materials harmonize lipidomics across MS-based detection platforms and laboratories
【24h】

Shared reference materials harmonize lipidomics across MS-based detection platforms and laboratories

机译:共享参考资料协调基于MS的检测平台和实验室的脂质族学

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Quantitative MS of human plasma lipids is a promising technology for translation into clinical applications. Current MS-based lipidomic methods rely on either direct infusion (DI) or chromatographic lipid separation methods (including reversed phase and hydrophilic interaction LC). However, the use of lipid markers in laboratory medicine is limited by the lack of reference values, largely because of considerable differences in the concentrations measured by different laboratories worldwide. These inconsistencies can be explained by the use of different sample preparation protocols, method-specific calibration procedures, and other experimental and data-reporting parameters, even when using identical starting materials. Here, we systematically investigated the roles of some of these variables in multiple approaches to lipid analysis of plasma samples from healthy adults by considering: 1) different sample introduction methods (separation vs. DI methods); 2) different MS instruments; and 3) between-laboratory differences in comparable analytical platforms. Each of these experimental variables resulted in different quantitative results, even with the inclusion of isotope-labeled internal standards for individual lipid classes. We demonstrated that appropriate normalization to commonly available reference samples (i.e., "shared references") can largely correct for these systematic method-specific quantitative biases. Thus, to harmonize data in the field of lipidomics, in-house long-term references should be complemented by a commonly available shared reference sample, such as NIST SRM 1950, in the case of human plasma.
机译:人血浆脂质的定量MS是一种有前途的转化为临床应用的技术。基于基于MS的脂质方法依赖于直接输注(DI)或色谱脂质分离方法(包括反相和亲水性相互作用LC)。然而,在实验室药物中使用脂质标记物受到缺乏参考值的限制,主要是因为全世界不同实验室测量的浓度相当差异。即使在使用相同的原料时,也可以通过使用不同的样品制备方案,方法特定校准程序和其他实验和数据报告参数来解释这些不一致。在这里,我们通过考虑:1)不同的样品引入方法(分离与DI方法),系统地研究了一些这些变量对来自健康成人的血浆样本的血脂分析的脂质分析的作用。 2)不同的MS仪器; 3)可比分析平台的实验室差异。这些实验变量中的每一个导致不同的定量结果,即使包含同位素标记的个体脂质类的内标。我们证明,对常规可用的参考样品(即“共享参考”)的适当归一化可以在很大程度上是对这些系统特异性定量偏差的校正。因此,为了协调脂类动物领域中的数据,在人类血浆的情况下,应通过常用的共享参考样品(例如NIST SRM 1950)互补的内部长期参考。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号